Embrionary way to create a fatty liver in portal hypertension

Portal hypertension in the rat by triple partial portal vein ligation produces an array of splanchnic and systemic disorders, including hepatic steatosis. In the current review these alterations are considered components of a systemic inflammatory response that would develop through three overlapping phenotypes: The neurogenic, the immune and the endocrine. These three inflammatory phenotypes could resemble the functions expressed during embryonic development of mammals. In turn, the inflammatory phenotypes would be represented in the embryo by two functional axes, that is, a coelomic-amniotic axis and a trophoblastic yolk-sac or vitelline axis. In this sense, the inflammatory response developed after triple partial portal vein ligation in the rat would integrate both functional embryonic axes on the liver interstitial space of Disse. If so, this fact would favor the successive development of steatosis, steatohepatitis and fibrosis. Firstly, these recapitulated embryonic functions would produce the evolution of liver steatosis. In this way, this fat liver could represent a yolk-sac-like in portal hypertensive rats. After that, the systemic recapitulation of these embryonic functions in experimental prehepatic portal hypertension would consequently induce a gastrulation-like response in which a hepatic wound healing reaction or fibrosis occur. In conclusion, studying the mechanisms involved in embryonic development could provide key results for a better understanding of the nonalcoholic fatty liver disease etiopathogeny.

[1]  P. Newsome,et al.  Non-alcoholic fatty liver disease in 2016. , 2016, British medical bulletin.

[2]  Lynne Pearce,et al.  Non-alcoholic fatty liver disease. , 2016, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[3]  S. Hollenberg,et al.  The Circulatory System in Liver Disease. , 2016, Critical care clinics.

[4]  F. Chisari,et al.  Immunosurveillance of the Liver by Intravascular Effector CD8+ T Cells , 2015, Cell.

[5]  R. Moreau,et al.  Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. , 2015, Journal of hepatology.

[6]  R. Groszmann,et al.  Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. , 2015, Journal of hepatology.

[7]  Kazuaki Chayama,et al.  Nonalcoholic fatty liver disease and cardiovascular disease. , 2014, Current pharmaceutical design.

[8]  L. Liaudet,et al.  The role of oxidative stress during inflammatory processes , 2013, Biological chemistry.

[9]  N. Wiernsperger Hepatic function and the cardiometabolic syndrome , 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.

[10]  J. Breuss,et al.  Cold induces reactive oxygen species production and activation of the NF‐kappa B response in endothelial cells and inflammation in vivo , 2013, Journal of thrombosis and haemostasis : JTH.

[11]  P. García-Rovés,et al.  Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: Cause or consequence? , 2013, Free radical research.

[12]  G. Tarantino,et al.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? , 2013, World journal of gastroenterology.

[13]  H. Nishina,et al.  The expanding role of fish models in understanding non-alcoholic fatty liver disease , 2013, Disease Models & Mechanisms.

[14]  D. Häussinger,et al.  Hepatic stem cell niches. , 2013, The Journal of clinical investigation.

[15]  Y. Nie,et al.  Association between metabolic syndrome and the development of non-alcoholic fatty liver disease , 2013, Experimental and therapeutic medicine.

[16]  A. Caraffa,et al.  Vascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation , 2013, International journal of immunopathology and pharmacology.

[17]  M. Michalska,et al.  Influence of Block of NF-Kappa B Signaling Pathway on Oxidative Stress in the Liver Homogenates , 2013, Oxidative medicine and cellular longevity.

[18]  M. Aller,et al.  Surgical inflammatory stress: the embryo takes hold of the reins again , 2013, Theoretical Biology and Medical Modelling.

[19]  C. Hellerbrand Hepatic stellate cells—the pericytes in the liver , 2013, Pflügers Archiv - European Journal of Physiology.

[20]  M. Aller,et al.  The risk association between experimental portal hypertension and an aortic atherosclerosis‐like disease , 2013, Hepatology.

[21]  Michael T Longaker,et al.  Soft tissue mechanotransduction in wound healing and fibrosis. , 2012, Seminars in cell & developmental biology.

[22]  M. Aller,et al.  Portal hypertension-related inflammatory phenotypes: From a vitelline and amniotic point of view , 2012 .

[23]  J. García‐Pagán,et al.  Functional aspects on the pathophysiology of portal hypertension in cirrhosis. , 2012, Journal of hepatology.

[24]  M. Aller,et al.  The wound‐healing response and upregulated embryonic mechanisms: brothers‐in‐arms forever , 2012, Experimental dermatology.

[25]  J. Regadera,et al.  A wound-like inflammatory aortic response in chronic portal hypertensive rats. , 2012, Molecular immunology.

[26]  Y. Soejima,et al.  Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , 2012, World journal of gastroenterology.

[27]  G. Kanel,et al.  Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. , 2012, Gastroenterology.

[28]  Kazuo Tanishita,et al.  Spatio-temporal control of hepatic stellate cell-endothelial cell interactions for reconstruction of liver sinusoids in vitro. , 2012, Tissue engineering. Part A.

[29]  M. Aller,et al.  Portal hypertensive cardiovascular pathology: the rescue of ancestral survival mechanisms? , 2012, Clinics and research in hepatology and gastroenterology.

[30]  G. Parker,et al.  Immune Functioning in Non lymphoid Organs: The Liver , 2012, Toxicologic pathology.

[31]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[32]  Giorgio Saracco,et al.  The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study , 2011, Hepatology.

[33]  J. Newton,et al.  Autonomic dysfunction in chronic liver disease , 2011, Hepatic medicine : evidence and research.

[34]  Guojun Sheng,et al.  Yolk sac endoderm is the major source of serum proteins and lipids and is involved in the regulation of vascular integrity in early chick development , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  Jonathan C. Cohen,et al.  Human Fatty Liver Disease: Old Questions and New Insights , 2011, Science.

[36]  M. Nalls,et al.  Associations of Visceral and Liver Fat With the Metabolic Syndrome Across the Spectrum of Obesity: The AGES‐Reykjavik Study , 2011, Obesity.

[37]  A. David,et al.  Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid , 2011, Current opinion in obstetrics & gynecology.

[38]  M. Aller,et al.  Gut-Brain Chemokine Changes in Portal Hypertensive Rats , 2011, Digestive Diseases and Sciences.

[39]  S. Coulon,et al.  Angiogenesis in chronic liver disease and its complications , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[40]  D. Thabut,et al.  Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? , 2010, Journal of hepatology.

[41]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[42]  M. Aller,et al.  Pathological axes of wound repair: Gastrulation revisited , 2010, Theoretical Biology and Medical Modelling.

[43]  I. Weissman,et al.  The origin and fate of yolk sac hematopoiesis: application of chimera analyses to developmental studies. , 2010, The International journal of developmental biology.

[44]  M. Aller,et al.  Partial hepatectomy, partial portal vein stenosis and mesenteric lymphadenectomy increase splanchnic mast cell infiltration in the rat. , 2010, Acta histochemica.

[45]  W. Payne,et al.  Amnion-Derived Cellular Cytokine Solution (ACCS) Promotes Migration of Keratinocytes and Fibroblasts , 2010, Annals of plastic surgery.

[46]  C. Tseng,et al.  Isolation of Mesenchymal Stem Cells with Neurogenic Potential from the Mesoderm of the Amniotic Membrane , 2010, Cells Tissues Organs.

[47]  C. Cray,et al.  Acute phase response in animals: a review. , 2009, Comparative medicine.

[48]  D. Häussinger,et al.  The niche of stellate cells within rat liver , 2009, Hepatology.

[49]  M. Pinzani,et al.  Hepatic wound repair , 2009, Fibrogenesis & tissue repair.

[50]  M. Baron,et al.  Embryonic fates for extraembryonic lineages: New perspectives , 2009, Journal of cellular biochemistry.

[51]  M. Tufail,et al.  Molecular characteristics of insect vitellogenins. , 2008, Journal of insect physiology.

[52]  M. Aller,et al.  Microsurgery in Liver Research , 2008 .

[53]  F. Poordad,et al.  Review article: diagnosis and treatment of non‐alcoholic fatty liver disease , 2008, Alimentary pharmacology & therapeutics.

[54]  A. Freilinger,et al.  Human amniotic fluid stem cells: a new perspective , 2008, Amino Acids.

[55]  Y. Ohtani,et al.  Lymph Circulation in the Liver , 2008, Anatomical record.

[56]  A. Geerts,et al.  Regulation of Sinusoidal Perfusion in Portal Hypertension , 2008, Anatomical record.

[57]  Jia Luo,et al.  Acute stretch promotes endothelial cell proliferation in wounded healing mouse skin , 2008, Archives of Dermatological Research.

[58]  J. McDougall,et al.  Central neural activation of hyperdynamic circulation in portal hypertensive rats depends on vagal afferent nerves , 2008, Gut.

[59]  M. Yeh,et al.  Pathology of nonalcoholic fatty liver disease. , 2007, American journal of clinical pathology.

[60]  M. Aller,et al.  The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension , 2007, Journal of Translational Medicine.

[61]  M. Aller,et al.  Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats. , 2006, World journal of gastroenterology.

[62]  C. Bellini,et al.  Lymphodynamics in the fetus and newborn. , 2006, Lymphology.

[63]  M. Mejías,et al.  Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. , 2006, Journal of hepatology.

[64]  D. Ingber,et al.  Cellular mechanotransduction: putting all the pieces together again , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  E. Rondonotti,et al.  Portal hypertensive enteropathy. , 2006, Gastrointestinal endoscopy clinics of North America.

[66]  寺田 周美 Transfer of maternal cholesterol to embryo and fetus in pregnant mice , 2006 .

[67]  R. Groszmann,et al.  The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule , 2006, Hepatology.

[68]  C. Puoti,et al.  Steatosis and portal hypertension. , 2005, European review for medical and pharmacological sciences.

[69]  M. Aller,et al.  Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat , 2005, Journal of gastroenterology and hepatology.

[70]  J. Rodés,et al.  Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. , 2005, Journal of hepatology.

[71]  Titiz Izzet,et al.  Oxidative stress in portal hypertension-induced rats with particular emphasis on nitric oxide and trace metals. , 2005, World journal of gastroenterology.

[72]  M. Aller,et al.  Tumor Necrosis Factor-α, Interleukin-1β and Nitric Oxide: Induction of Liver Megamitochondria in Prehepatic Portal Hypertensive Rats , 2005, World Journal of Surgery.

[73]  M. Alonso,et al.  Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension. , 2005, Hepato-gastroenterology.

[74]  M. Aller,et al.  Posttraumatic Inflammation is a Complex Response Based on the Pathological Expression of the Nervous, Immune, and Endocrine Functional Systems , 2004, Experimental biology and medicine.

[75]  Anders Goksøyr,et al.  Eggshell and egg yolk proteins in fish: hepatic proteins for the next generation: oogenetic, population, and evolutionary implications of endocrine disruption , 2003, Comparative hepatology.

[76]  K. Sharkey,et al.  Hyperdynamic circulation in portal‐hypertensive rats is dependent on central c‐fos gene expression , 2002, Hepatology.

[77]  E. Jauniaux,et al.  Nutrition of the human fetus during the first trimester--a review. , 2001, Placenta.

[78]  M. Aller,et al.  Increased Duodenal Mucosa Infiltration by Mast Cells in Rats with Portal Hypertension , 2001, Digestive Surgery.

[79]  E. Jauniaux,et al.  Fluid compartments of the embryonic environment. , 2000, Human reproduction update.

[80]  D. Carnall Risk of cardiovascular disease , 2000, BMJ : British Medical Journal.

[81]  K. Kaneda,et al.  Phenotypical and morphological alterations to rat sinusoidal endothelial cells in arterialized livers after portal branch ligation. , 1999, Archives of histology and cytology.

[82]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[83]  E. Jauniaux,et al.  Protein and enzyme patterns in the fluid cavities of the first trimester gestational sac: relevance to the absorptive role of secondary yolk sac. , 1998, Molecular human reproduction.

[84]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[85]  C. Gostout,et al.  Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features. , 1992, The American journal of gastroenterology.

[86]  Vicente Arroyo,et al.  Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.

[87]  W W Lautt,et al.  Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. , 1985, The American journal of physiology.

[88]  H. Popper,et al.  Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.

[89]  S. Chien,et al.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.

[90]  E. Bevilacqua,et al.  Trophoblast phagocytic program: roles in different placental systems. , 2010, The International journal of developmental biology.

[91]  S. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[92]  M. Aller,et al.  Lipids in Health and Disease , 2008 .

[93]  M. Aller,et al.  Tumor necrosis factor-alpha, interleukin-1beta and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats. , 2005, World journal of surgery.

[94]  W. Collins,et al.  Relationship between protein concentrations in embryological fluids and maternal serum and yolk sac size during human early pregnancy. , 1994, Human reproduction.

[95]  M. Aller,et al.  Theoretical Biology and Medical Modelling Open Access Inflammation: a Way to Understanding the Evolution of Portal Hypertension , 2022 .